Stoke Therapeutics, Inc. (STOK)
Stoke Therapeutics, Inc. (STOK) Insider Trading
Directors, officers and holders of more than 10% of STOK report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 289 transactions on file: 0 with code P, 18 with code S and 32 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | S Sale | 627 | $26.33 | $16,509 |
| Oct 1, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | S Sale | 1,051 | $26.16 | $27,494 |
| Sep 23, 2026 | Cumbo Alexander | Director | A Award | 39,674 | Not measured | Not measured |
| Sep 1, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | S Sale | 1,600 | $31.06 | $49,691 |
| Sep 1, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | S Sale | 3,945 | $30.51 | $120,370 |
| Aug 18, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | S Sale | 242 | $32.47 | $7,857 |
| Aug 18, 2026 | Kaye Edward M. MD | Director | S Sale | 637 | $32.47 | $20,682 |
| Aug 18, 2026 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | S Sale | 2,716 | $32.01 | $86,932 |
| Aug 18, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | S Sale | 4,525 | $32.01 | $144,833 |
| Aug 18, 2026 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | S Sale | 145 | $32.47 | $4,708 |
| Aug 18, 2026 | Kaye Edward M. MD | Director | S Sale | 11,930 | $32.01 | $381,846 |
| Aug 14, 2026 | Kaye Edward M. MD | Director | M Exercise | 26,250 | Not measured | Not measured |
| Aug 14, 2026 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | M Exercise | 6,000 | Not measured | Not measured |
| Aug 14, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | M Exercise | 10,000 | Not measured | Not measured |
| Aug 14, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | M Exercise | 10,000 | Not measured | Not measured |
| Aug 14, 2026 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | M Exercise | 6,000 | Not measured | Not measured |
| Aug 14, 2026 | Kaye Edward M. MD | Director | M Exercise | 26,250 | Not measured | Not measured |
| Aug 3, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | S Sale | 5,907 | $28.95 | $171,008 |
| Aug 3, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | S Sale | 1,269 | $29.45 | $37,377 |
| Jul 16, 2026 | Harrison Seth Loring | Director | G Gift | 7,639 | Not measured | Not measured |
| Jul 16, 2026 | Harrison Seth Loring | Director | G Gift | 29,555 | Not measured | Not measured |
| Jul 16, 2026 | Harrison Seth Loring | Director | G Gift | 11,650 | Not measured | Not measured |
| Jul 16, 2026 | Harrison Seth Loring | Director | G Gift | 21,000 | Not measured | Not measured |
| Jul 16, 2026 | Harrison Seth Loring | Director | G Gift | 17,786 | Not measured | Not measured |
| Jul 16, 2026 | Harrison Seth Loring | Director | G Gift | 21,000 | Not measured | Not measured |
| Jul 16, 2026 | Harrison Seth Loring | Director | G Gift | 19,441 | Not measured | Not measured |
| Jul 16, 2026 | Harrison Seth Loring | Director | G Gift | 29,747 | Not measured | Not measured |
| Jul 16, 2026 | Harrison Seth Loring | Director | G Gift | 19,441 | Not measured | Not measured |
| Jul 16, 2026 | Harrison Seth Loring | Director | G Gift | 14,777 | Not measured | Not measured |
| Jul 16, 2026 | Harrison Seth Loring | Director | G Gift | 17,786 | Not measured | Not measured |
| Jul 16, 2026 | Harrison Seth Loring | Director | G Gift | 7,639 | Not measured | Not measured |
| Jul 16, 2026 | Harrison Seth Loring | Director | G Gift | 29,747 | Not measured | Not measured |
| Jul 16, 2026 | Harrison Seth Loring | Director | G Gift | 14,777 | Not measured | Not measured |
| Jul 16, 2026 | Harrison Seth Loring | Director | G Gift | 29,555 | Not measured | Not measured |
| Jul 16, 2026 | Harrison Seth Loring | Director | G Gift | 11,650 | Not measured | Not measured |
| Jul 15, 2026 | McCauley Thomas | Chief Scientific Officer | A Award | 225,000 | Not measured | Not measured |
| Jul 1, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | S Sale | 6,728 | $32.62 | $219,434 |
| Jul 1, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | S Sale | 500 | $33.27 | $16,634 |
| Jun 16, 2026 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | S Sale | 1,457 | $29.95 | $43,637 |
| Jun 3, 2026 | LEVIN ARTHUR A | Director | A Award | 17,786 | Not measured | Not measured |
| Jun 3, 2026 | Burstein Jennifer | Director | A Award | 17,786 | Not measured | Not measured |
| Jun 3, 2026 | Smith Julie | Director | A Award | 17,786 | Not measured | Not measured |
| Jun 3, 2026 | Harrison Seth Loring | Director | A Award | 17,786 | Not measured | Not measured |
| Jun 3, 2026 | TZIANABOS ARTHUR | Director | A Award | 17,786 | Not measured | Not measured |
| Jun 3, 2026 | Kaye Edward M. MD | Director | A Award | 17,786 | Not measured | Not measured |
| Jun 3, 2026 | Krainer Adrian R. | Director | A Award | 17,786 | Not measured | Not measured |
| Jun 1, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | S Sale | 1,795 | $30.58 | $54,891 |
| May 1, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | S Sale | 2,243 | $32.79 | $73,548 |
| Apr 3, 2026 | Kahn Clare | Director | A Award | 30,782 | Not measured | Not measured |
| Apr 1, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | S Sale | 1,838 | $32.66 | $60,029 |
The full Form 4 history is on the STOK company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.